治疗性疫苗市场规模预计将从 2024 年的 12.4494 亿美元增至 2031 年的 29.3457 亿美元。预计 2024-2031 年期间的复合年增长率 为13.0%。疫苗技术的进步可能仍是治疗性疫苗市场的主要趋势。
治疗性疫苗市场分析
由于免疫疗法的进步以及癌症和传染病等慢性病的日益流行,治疗性疫苗市场预计在未来几年将出现大幅增长。这些疫苗通过刺激免疫系统瞄准和摧毁患病细胞来治疗疾病。治疗性疫苗市场有望实现显着增长,个性化医疗和技术创新的关注度不断上升。政府投资、医疗保健需求的增加以及新型疫苗平台的开发等因素进一步促进了其扩张。由于医疗保健投资的增加、疫苗技术的进步以及对有针对性的治疗解决方案的需求不断增长,预计市场将经历强劲增长。
治疗性疫苗市场概况
治疗性疫苗市场正在迅速发展,这得益于免疫疗法的进步和人们对疫苗治疗方法的认识不断提高。市场尤其受到癌症免疫疗法创新的推动,该疗法涉及开发疗法以增强免疫系统识别和摧毁肿瘤细胞的能力。慢性病的日益流行和个性化医疗意识的不断提高进一步刺激了对治疗性疫苗的需求。德国癌症研究中心 ( DKFZ ) 在癌症 免疫疗法和疫苗开发方面开展了开创性研究,为该国作为医疗创新中心的作用做出了贡献。2024 年 8 月,DKFZ的研究人员推出了一种旨在提高 HPV 疫苗接种率的新型疫苗,针对致癌的人乳头瘤病毒(HPV)。这种创新疫苗具有成本效益,并已显示出保护小鼠免受几乎所有类型的致癌 HPV 侵害的有效性。该疫苗还能刺激针对 HPV 感染细胞的细胞免疫反应,并对现有感染具有治疗作用。研究人员的最终目标是为已经感染 HPV 的个体开发治疗性疫苗,特别是那些可能已经患上 HPV 相关癌症或癌前病变的个体。因此,强大的研究生态系统以及学术机构、医院和生物技术公司之间的合作努力正在加速德国新型治疗性疫苗的开发。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
治疗性疫苗市场驱动因素和机遇
慢性病患病率上升促进市场增长
由于衰老、生活方式改变和环境影响等因素,癌症、神经系统疾病和自身免疫性疾病等慢性病在全球范围内变得越来越普遍。根据世界卫生组织 (WHO) 的《2023 年非传染性疾病情况说明书》,这些疾病每年导致全球 4100 万人死亡,相当于总死亡率的 74%。根据《全球癌症事实与数据》,2022 年诊断出的癌症病例约为 2000 万例,同年有 970 万人死于该疾病。此外,根据 2024 年 2 月发表的一篇题为《自身免疫性疾病的全球格局》的文章,自身免疫性疾病影响了工业世界人口的 5-10%;它还指出,约 5000 万美国人患有自身免疫性疾病。此外,根据世卫组织多发性硬化症情况说明书,截至 2023 年 8 月,全球有超过 180 万人患有多发性硬化症。
因此,各种慢性病发病率的激增凸显了对创新治疗干预措施的迫切需求。治疗性疫苗旨在治疗现有疾病,而不是预防其发病。这些疫苗刺激人体免疫系统以针对和治疗特定疾病。在癌症治疗中,Sipuleucel-T(Provenge)疫苗已显示出提高前列腺癌患者生存率的潜力。在对慢性病创新治疗的需求中,治疗性疫苗有望为长期疾病管理提供一种新方法,并改善全球患者的治疗效果。因此,慢性病患病率的上升推动了治疗性疫苗市场的增长。
扩展产品线以创造增长机会
随着全球对创新治疗方案的需求不断增长,治疗性疫苗领域见证了疫苗开发的强劲投资和进步,这主要得益于越来越多的临床候选疫苗进入各个开发阶段。生物技术研发工作产生了针对各种疾病的尖端治疗性疫苗,特别是新型感染和癌症等慢性疾病。Moderna 的 mRNA-4157 目前处于第 2 阶段试验阶段,早期结果显示与检查点抑制剂联合用于治疗黑色素瘤具有良好的潜力。除了肿瘤学之外,治疗性疫苗产品线也在自身免疫性疾病和传染病(HIV、HPV 和 HBV 感染)等领域不断增长。
随着针对各种疾病的候选疫苗产品线不断扩大,治疗性疫苗在满足尚未满足的医疗需求方面具有巨大潜力。因此,强大的治疗性疫苗候选产品线意味着治疗性疫苗市场存在丰厚的增长机会。
治疗性疫苗市场报告细分分析
治疗性疫苗市场分析的基础关键部分是产品、技术和最终用户。
- 根据产品,治疗性疫苗市场分为癌症疫苗、传染病疫苗和其他疫苗。2024 年,癌症疫苗占据了最大的市场份额。
- 根据技术,市场分为同种异体疫苗和自体疫苗。自体疫苗部分在 2024 年占据了治疗性疫苗的较大市场份额。
- 就最终用户而言,治疗性疫苗市场分为医院、诊所和其他。医院部门在 2024 年占据了市场主导地位。
治疗性疫苗市场份额按地区分析
治疗疫苗市场报告的地理范围分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。
2024 年,北美占据了相当大的市场份额。区域市场的增长是由癌症发病率上升、研发投入增加以及产品发布激增推动的。此外,新产品开发、监管部门批准、合作和收购等战略举措进一步推动了该地区治疗性疫苗市场的扩张。根据美国癌症协会的数据,2022 年,美国诊断出超过 190 万例新癌症病例,造成约 61 万人死亡。2024 年,美国有 200 万人被诊断出患有癌症。癌症病例的增加最终推动了对创新治疗方案的需求。治疗性疫苗旨在刺激免疫系统靶向癌细胞,为传统疗法提供了有希望的替代方案。2010 年,Provenge (sipuleucel-T) 成为首个获得 FDA 批准的治疗性癌症疫苗。它是专门为前列腺癌设计的,凸显了免疫疗法提供延长寿命治疗的潜力。案件数量的不断增长推动了研发投资,并鼓励了企业和学术机构之间的合作。
加拿大政府通过资助计划和提供补助金来支持早期癌症研究,发挥着至关重要的作用。2024 年 9 月,加拿大免疫工程和生物制造中心 (CIEBH) 内不列颠哥伦比亚大学 (UBC) 的研究人员获得了超过 3140 万美元的省级资助,用于三个项目,旨在推动不列颠哥伦比亚省为所有加拿大人开发疫苗和治疗方法。这笔资金由不列颠哥伦比亚知识发展基金 (BCKDF) 提供,将用于建立尖端研究基础设施,包括位于不列颠哥伦比亚大学温哥华校区的先进治疗制造设施 (ATMF)。该设施将用于开发和生产符合加拿大卫生部严格的临床试验质量标准的临床级治疗方法。这些项目符合 CIEBH 的使命,即使不列颠哥伦比亚省和加拿大成为下一代免疫疗法的全球领导者,包括 mRNA 疫苗、抗体治疗以及基于细胞和基因的疗法。
治疗性疫苗市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响治疗性疫苗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的治疗性疫苗市场细分和地理位置。

- 获取治疗性疫苗市场的区域特定数据
治疗性疫苗市场报告范围
报告属性 | 细节 |
---|---|
2024 年的市场规模 | 12.4494亿美元 |
2031 年市场规模 | 29.3457亿美元 |
全球复合年增长率(2024 - 2031) | 13.0% |
史料 | 2021-2023 |
预测期 | 2024-2031 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
治疗性疫苗市场参与者密度:了解其对业务动态的影响
治疗性疫苗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在治疗性疫苗市场运营的主要公司有:
- 丹德里昂
- BioNTech 公司
- 印度血清研究所私人有限公司,
- 默克公司
- 安进公司
- ISA制药公司
免责声明:上面列出的公司没有按照任何特定顺序排列。

- 了解治疗性疫苗市场的主要参与者概况
治疗性疫苗市场新闻和最新发展
治疗性疫苗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。治疗性疫苗市场的一些发展如下所列:
- TheraVectys 宣布已招募首位患者参加 I/IIa 期临床试验,该试验评估肿瘤治疗疫苗 Lenti-HPV-07 对 HPV 诱发癌症的治疗效果。Lenti-HPV-07 疫苗基于巴斯德-TheraVectys 联合实验室开发的慢病毒载体技术平台,TheraVectys 在过去二十年中率先采用了该技术。(来源:TheraVectys,新闻稿,2024 年 10 月)
- 印度血清研究所是全球按剂量计算最大的疫苗制造商,它与 ImmunityBio, Inc. 达成了一项独家全球协议,为 ImmunityBio 供应卡介苗 (BCG)。该交易包括生产获准在美国以外使用的标准 BCG 和目前正在测试的下一代重组 BCG (iBCG)。iBCG 旨在与 ImmunityBio 的 ANKTIVA 结合使用,用于已获批准和未来可能出现的适应症,但须经监管部门批准。两家公司将合作加快在欧洲进行的 iBCG 第 2 阶段临床试验。(来源:印度血清研究所私人有限公司,新闻稿,2024 年 5 月)
治疗性疫苗市场报告覆盖范围和交付成果
“治疗性疫苗市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:
- 治疗性疫苗市场规模及全球、区域和国家层面所有主要细分市场的预测
- 治疗性疫苗市场趋势和市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST 和 SWOT 分析
- 治疗性疫苗市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者以及治疗性疫苗市场的最新发展
- 详细的公司简介
- 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
- PEST 和 SWOT 分析
- 市场规模价值/数量 - 全球、区域、国家
- 行业和竞争格局
- Excel 数据集


- Health Economics and Outcome Research (HEOR) Services Market
- Legal Case Management Software Market
- Smart Locks Market
- Fixed-Base Operator Market
- Influenza Vaccines Market
- Electronic Shelf Label Market
- Virtual Pipeline Systems Market
- Medical Collagen Market
- Europe Industrial Chillers Market
- Bioremediation Technology and Services Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
常见问题
The market is estimated to register a CAGR of 13.0% during the forecast period.
The rising prevalence of chronic diseases, and increasing investments and funding for vaccine development are noteworthy factors contributing to the market growth.
The market is estimated to reach a value of US$ 2,934.57 million by 2031.
Dendreon, BioNTech SE, Serum Institute of India Pvt. Ltd, Merck & Co Inc, Amgen Inc, ISA Pharmaceuticals BV, INOVIO Pharmaceuticals Inc, Transgene SA, THERAVECTYS SA, and CureVac SE are among the key players operating in the therapeutic vaccines market.
North America dominated the therapeutic vaccines market in 2024.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Therapeutic Vaccines Market
- Dendreon
- BioNTech SE
- Serum Institute of India Pvt. Ltd
- Merck & Co Inc
- Amgen Inc.
- ISA Pharmaceuticals BV
- INOVIO Pharmaceuticals Inc
- Transgene SA
- THERAVECTYS SA
- CureVac SE
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.